Factorial Energy's SPAC merger saw 84% of public shareholders take $10.42 cash, leaving 40M-45M shares as "free float" for ...
REC-4881 is among the first AI-enabled programs to advance a registrational Phase 3 trial design for a disease with no ...
RXRX is trading near the bottom of its 52-week range and below its 200-day simple moving average. Price change The price of RXRX shares has decreased $0.27 since the market last closed. This is a 9.93 ...
FAC is trading near the bottom of its 52-week range and below its 200-day simple moving average. Price change The price of FAC shares has decreased $0.33 since the market last closed. This is a 8.78% ...
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...